IP Group: Autifony Signs Up To $770 Mln Worth Global Licencing Deal With Jazz Pharma

(RTTNews) - British intellectual property investor IP Group Plc (IPO.L) announced Tuesday that its portfolio company Autifony Therapeutics Ltd has entered into an exclusive global licensing agreement with Jazz Pharmaceuticals plc (JAZZ). https://www.nasdaq.com/articles/ip-group:-autifony-signs-up-to-$770-mln-worth-global-licencing-deal-with-jazz-pharma